EIF4A3 and glioblastoma: Our findings indicate that EIF4A3-induced circCABIN1 functions in an important underlying mechanism in TMZ resistance through modulation of the miR-637/OLFML3 signaling pathway, which could provide pivotal potential therapeutic targets for GBM.